Tirzepatide Works Just as Well and as Safely for Adults Over 65
This analysis suggests tirzepatide may be a reasonable weight option for older adults after weighing risks.
Tirzepatide is the popular GLP-1 weight loss drug also sold as Mounjaro and Zepbound. This look back at big trials found it helped adults over 65 lose weight and improve heart and blood sugar health. The benefits and side effects matched what younger adults saw, with no new risks for older bodies.
Conflict of Interest Disclosure: Tirzepatide is made by Eli Lilly, which runs the SURMOUNT and SUMMIT trials.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchWhy GLP-1 Weight Loss Can Cost You Muscle After 60
GLP-1 drugs like Ozempic help older adults shed weight, but a lot of that loss can be muscle.
A New Drug Combo May Protect Muscle During Ozempic-Style Weight Loss
Drugs like semaglutide help people lose weight but often shrink muscle too.
Where You Live May Shape How Well Your Heart Ages
Researchers mapped older adults in Ohio and found clear pockets where hearts aged better.